Related Experiment Video
Updated: Feb 5, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Ser46-Phosphorylated MARCKS Is a Marker of Neurite Degeneration at the Pre-aggregation Stage in PD/DLB Pathology
Kyota Fujita1, Hidenori Homma1, Kanoh Kondo1
1Department of Neuropathology, Medical Research Institute and Center for Brain Integration Research, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
Abstract:
Phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) reflects neurite degeneration at the early stage of Alzheimer's disease (AD), before extracellular Aβ aggregates are histologically detectable. Here, we demonstrate that similar changes in MARCKS occur in Parkinson's disease (PD) and dementia with Lewy bodies (DLB) pathologies in both mouse models and human patients. The increase in the level of pSer46-MARCKS began before α-synuclein aggregate formation, at a time when human α-Syn-BAC-Tg/GBA-hetero-KO mice exhibited no symptoms, and was sustained during aging, consistent with the pattern in human postmortem brains. The results strongly imply a common mechanism of pre-aggregation neurite degeneration in AD and PD/DLB pathologies.
Insights
Early-stage Alzheimer
Area of Science:
- Neuroscience
- Neuropathology
- Molecular Biology
Background:
- Phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) is an early indicator of neurite degeneration in Alzheimer's disease (AD).
- This degeneration occurs before extracellular amyloid-beta (Aβ) aggregates are detectable.
- A common mechanism for pre-aggregation neurite degeneration may exist across neurodegenerative diseases.
Purpose of the Study:
- To investigate if similar MARCKS phosphorylation changes occur in Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
- To determine the temporal relationship between MARCKS phosphorylation and alpha-synuclein aggregation in PD/DLB models.
- To explore a potential shared pathway in early neurodegeneration.
Main Methods:
- Analysis of MARCKS phosphorylation levels in mouse models of PD/DLB and human postmortem brain tissues.
- Correlation of pSer46-MARCKS levels with the presence and stage of alpha-synuclein aggregation.
- Assessment of MARCKS changes in asymptomatic mouse models.
Main Results:
- Increased levels of phosphorylated MARCKS (pSer46-MARCKS) were observed in mouse models and human patients with PD and DLB.
- Elevated pSer46-MARCKS preceded alpha-synuclein aggregate formation in asymptomatic mouse models.
- These changes were sustained during aging and consistent with human brain pathology.
Conclusions:
- MARCKS phosphorylation is a conserved early event in neurite degeneration across AD, PD, and DLB.
- This finding suggests a common pre-aggregation mechanism contributing to neurodegeneration in these distinct pathologies.
- MARCKS phosphorylation may serve as a potential early biomarker for multiple neurodegenerative diseases.
More Related Videos
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Time-Domain Interpretation of PD Control
Consider the example of control of motor torque. Initially, a positive...
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Frequency-Domain Interpretation of PD Control
The proportional control gain, combined with the...

